IBDEI0LO ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9752,2)
 ;;=^5019672
 ;;^UTILITY(U,$J,358.3,9753,0)
 ;;=N87.9^^39^417^35
 ;;^UTILITY(U,$J,358.3,9753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9753,1,3,0)
 ;;=3^Dysplasia of Cervix Uteri,Unspec
 ;;^UTILITY(U,$J,358.3,9753,1,4,0)
 ;;=4^N87.9
 ;;^UTILITY(U,$J,358.3,9753,2)
 ;;=^5015877
 ;;^UTILITY(U,$J,358.3,9754,0)
 ;;=R30.0^^39^417^36
 ;;^UTILITY(U,$J,358.3,9754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9754,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,9754,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,9754,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,9755,0)
 ;;=N92.1^^39^417^39
 ;;^UTILITY(U,$J,358.3,9755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9755,1,3,0)
 ;;=3^Excessive/Frequent Menstruation w/ Irregular Cycle
 ;;^UTILITY(U,$J,358.3,9755,1,4,0)
 ;;=4^N92.1
 ;;^UTILITY(U,$J,358.3,9755,2)
 ;;=^5015909
 ;;^UTILITY(U,$J,358.3,9756,0)
 ;;=Z08.^^39^417^41
 ;;^UTILITY(U,$J,358.3,9756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9756,1,3,0)
 ;;=3^F/U Exam After Malig Neop Treatment
 ;;^UTILITY(U,$J,358.3,9756,1,4,0)
 ;;=4^Z08.
 ;;^UTILITY(U,$J,358.3,9756,2)
 ;;=^5062667
 ;;^UTILITY(U,$J,358.3,9757,0)
 ;;=Z80.3^^39^417^42
 ;;^UTILITY(U,$J,358.3,9757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9757,1,3,0)
 ;;=3^Family Hx of Breast CA
 ;;^UTILITY(U,$J,358.3,9757,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,9757,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,9758,0)
 ;;=Z80.49^^39^417^43
 ;;^UTILITY(U,$J,358.3,9758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9758,1,3,0)
 ;;=3^Family Hx of Genital Organ CA
 ;;^UTILITY(U,$J,358.3,9758,1,4,0)
 ;;=4^Z80.49
 ;;^UTILITY(U,$J,358.3,9758,2)
 ;;=^5063351
 ;;^UTILITY(U,$J,358.3,9759,0)
 ;;=Z80.41^^39^417^44
 ;;^UTILITY(U,$J,358.3,9759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9759,1,3,0)
 ;;=3^Family Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,9759,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,9759,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,9760,0)
 ;;=N73.9^^39^417^47
 ;;^UTILITY(U,$J,358.3,9760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9760,1,3,0)
 ;;=3^Female Pelvic Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,9760,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,9760,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,9761,0)
 ;;=N60.32^^39^417^48
 ;;^UTILITY(U,$J,358.3,9761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9761,1,3,0)
 ;;=3^Fibrosclerosis,Left Breast
 ;;^UTILITY(U,$J,358.3,9761,1,4,0)
 ;;=4^N60.32
 ;;^UTILITY(U,$J,358.3,9761,2)
 ;;=^5015780
 ;;^UTILITY(U,$J,358.3,9762,0)
 ;;=N60.31^^39^417^49
 ;;^UTILITY(U,$J,358.3,9762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9762,1,3,0)
 ;;=3^Fibrosclerosis,Right Breast
 ;;^UTILITY(U,$J,358.3,9762,1,4,0)
 ;;=4^N60.31
 ;;^UTILITY(U,$J,358.3,9762,2)
 ;;=^5015779
 ;;^UTILITY(U,$J,358.3,9763,0)
 ;;=Z01.411^^39^417^50
 ;;^UTILITY(U,$J,358.3,9763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9763,1,3,0)
 ;;=3^GYN Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,9763,1,4,0)
 ;;=4^Z01.411
 ;;^UTILITY(U,$J,358.3,9763,2)
 ;;=^5062622
 ;;^UTILITY(U,$J,358.3,9764,0)
 ;;=Z01.419^^39^417^1
 ;;^UTILITY(U,$J,358.3,9764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9764,1,3,0)
 ;;=3
 ;;^UTILITY(U,$J,358.3,9764,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,9764,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,9765,0)
 ;;=Z01.419^^39^417^51
 ;;^UTILITY(U,$J,358.3,9765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9765,1,3,0)
 ;;=3^GYN Exam w/ Normal Findings
